Basics Structure Therapeutics Inc. IPO Date: February 3, 2023 Sector: Healthcare Industry: Biotech Market Cap: $2.1B Activated in VL: True Average Daily Range Avg Daily Range: $1.07 | 3.18% Avg Daily Range (30 D): $1.01 | 3.04% Avg Daily Range (90 D): $0.80 | 3.08% Institutional Daily Volume Avg Daily Volume: .7M Avg Daily Volume (30 D): .96M Avg Daily Volume (90 D): .92M Trade Size Avg Trade Size (Sh.): 85 Avg Trade Size (Sh.) (30 D): 79 Avg Trade Size (Sh.) (90 D): 84 Institutional Trades Total Inst.Trades: 1,893 Avg Inst. Trade: $1.55M Avg Inst. Trade (30 D): $2.28M Avg Inst. Trade (90 D): $2.27M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $1.35M Avg Closing Trade (30 D): $2.09M Avg Closing Trade (90 D): $1.75M Avg Closing Volume: 42.27K     News Dec 7, 2025 @ 11:20 PM Structure Therapeutics to Report Data from ACCESS ... Source: Structure Therapeutics Inc. Sep 12, 2025 @ 12:15 PM This Under-the-Radar Healthcare Stock Could Soar i... Source: Prosper Junior Bakiny Aug 17, 2025 @ 11:15 AM This Healthcare Stock's Bad News Could Create a $1... Source: Prosper Junior Bakiny Jun 20, 2025 @ 11:30 PM Structure Therapeutics Announces Two Late-Breaking... Source: N/A Apr 14, 2025 @ 3:12 PM Why Eli Lilly, Novo Nordisk, and Viking Therapeuti... Source: Rich Smith Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.22 $-.37 $-.36 Diluted EPS $-1.22 $-.37 $-.36 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -210.69M $ -65.71M $ -61.66M Operating Income / Loss $ -247.61M $ -73.79M $ -70.45M Cost of Revenue $ $ $ Net Cash Flow $ -69.22M $ -44.11M $ -5.1M PE Ratio